Current Status (as of Early 2026) Scientific studies suggest a link between chemical hair relaxer use and cancer. A 2022…
Once known for its convenience – one shot every three months, Depo-Provera is now at the center of a major…
Fragile premature babies in Neonatal Intensive Care Units (NICUs) developed a life-threatening intestinal disease called necrotising enterocolitis (NEC), and hundreds…
PFAS, per- and polyfluoroalkyl substances often called “forever chemicals” continue to dominate headlines and court dockets in late 2025. As…
Thousands of patients across the United States are suing medical-device manufacturer Bard Access Systems over its PowerPort implantable catheter, alleging…
“Artificial Intelligence” (“A.I.”) is properly defined as being any technology that uses machine learning, natural language processing, or any other…
Lessons from Zantac and Paraquat Dismissals In complex tort litigation, particularly toxic torts and mass actions, proving causation is complicated…
“Failure to warn” (also referred to as a failure to provide adequate warnings, marketing warnings, labeling warnings, postmarket risk disclosures,…
Ozempic, a drug made by Novo Nordisk (a global pharmaceutical company based in Denmark), was approved by the U.S. FDA…
The Mass Tort Madness: You vs. the Avalanche of Cases Picture this: You just landed a major mass tort case.…
Mass torts cases are complex and often involve multiple plaintiffs who have suffered harm from the same product or action.…
On March 07, 2022, the California Supreme Court vide its ruling made it difficult for a plaintiff litigating in California…